{"url_path":"/sec/ueec/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1096938/0001477932-26-003228-index.html","accession_number":"0001477932-26-003228","cik":"0001096938","ticker":"UEEC","issuer_name":"United Health Products, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1096938/0001477932-26-003228-index.html","primary_entity_key":"0001096938","primary_entity_name":"United Health Products, Inc."},"word_count":343,"has_tables":true,"body_markdown":"**Item 6. Exhibits**\n\n \n\nThe following exhibits are filed with this report, or incorporated by reference as noted:\n\n \n\n[3.1](http://www.sec.gov/Archives/edgar/data/1096938/000147793214006555/ueec_ex31.htm)\n\n \n\n[Articles of Incorporation of the Company dated February 28, 1997 (1)](http://www.sec.gov/Archives/edgar/data/1096938/000147793214006555/ueec_ex31.htm)\n\n \n\n \n\n \n\n[3.2](http://www.sec.gov/Archives/edgar/data/1096938/000147793214006555/ueec_ex32.htm)\n\n \n\n[Amendment to Articles of Incorporation (1)](http://www.sec.gov/Archives/edgar/data/1096938/000147793214006555/ueec_ex32.htm)\n\n \n\n \n\n \n\n[3.3](http://www.sec.gov/Archives/edgar/data/1096938/000132612606000004/r-34.txt)\n\n \n\n[By-laws of the Company (2)](http://www.sec.gov/Archives/edgar/data/1096938/000132612606000004/r-34.txt)\n\n \n\n \n\n \n\n[3.4](http://www.sec.gov/Archives/edgar/data/1096938/000147793215004958/ueec_ex31.htm)\n\n \n\n[August 2015 Amendment to Articles of Incorporation (3)](http://www.sec.gov/Archives/edgar/data/1096938/000147793215004958/ueec_ex31.htm)\n\n \n\n \n\n \n\n[31.1](ueec_ex311.htm)\n\n \n\n[Certification of Principal Executive Officer*](ueec_ex311.htm)\n\n \n\n \n\n \n\n[31.2](ueec_ex312.htm)\n\n \n\n[Certification of Principal Financial Officer*](ueec_ex312.htm)\n\n \n\n \n\n \n\n[32.1](ueec_ex321.htm)\n\n \n\n[Section 1350 Certificate by Principal Executive Officer*](ueec_ex321.htm)\n\n \n\n \n\n \n\n[32.2](ueec_ex322.htm)\n\n \n\n[Section 1350 Certificate by Principal Financial Officer*](ueec_ex322.htm)\n\n \n\n \n\n27\n\n*Table of Contents*\n\n \n\n101.INS\n\n \n\nInline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).\n\n \n\n \n\n \n\n101.SCH\n\n \n\nInline XBRL Taxonomy Extension Schema Document.\n\n \n\n \n\n \n\n101.CAL\n\n \n\nInline XBRL Taxonomy Extension Calculation Linkbase Document.\n\n \n\n \n\n \n\n101.DEF\n\n \n\nInline XBRL Taxonomy Extension Definition Linkbase Document.\n\n \n\n \n\n \n\n101.LAB\n\n \n\nInline XBRL Taxonomy Extension Labels Linkbase Document.\n\n \n\n \n\n \n\n101.PRE\n\n \n\nInline XBRL Taxonomy Extension Presentation Linkbase Document.\n\n \n\n \n\n \n\n104\n\n \n\nCover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).\n\n___________\n\n* Filed herewith.\n\n \n\n(1)\n\nIncorporated by reference to the Company’s Form 10-Q for the quarter ended September 30, 2014.\n\n \n\n \n\n(2)\n\nIncorporated by reference to the Company’s Form 10-Q for the quarter ended June 30, 2022.\n\n \n\n \n\n(3)\n\nIncorporated by reference to Form 8-K dated August 7, 2015 – date of earliest event filed on August 10, 2015.\n\n \n\n \n\n28\n\n*Table of Contents*\n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.\n\n \n\n**UNITED HEALTH PRODUCTS, INC.**\n\nDated: May 15, 2026\n\nBy:\n\n*/s/ Brian Thom*\n\nBrian Thom\n\nPrincipal Executive Officer\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:\n\n \n\n**Signatures**\n\n**Title**\n\n**Date**\n\nBy:\n\n*/s/ Brian Thom*\n\n \n\nMay 15, 2026\n\nBrian Thom\n\nChief Executive Officer, Principal Executive and Financial Officer and Director\n\n \n\n \n\n \n\n \n\n \n\n \n\nBy:\n\n*/s/ Robert Denser*\n\nDirector\n\nMay 15, 2026\n\nRobert Denser\n\n \n\n \n\n29"}